BioNTech SE (BNTX) Cash from Investing Activities (2018 - 2026)

BioNTech SE has reported Cash from Investing Activities for 8 years, with the latest figure at -$3.2 billion in Q4 2025.

• Quarterly Cash from Investing Activities fell 589.38% year-over-year to -$3.2 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.0 billion (down 32.79% YoY) and the FY2025 annual result came in at -$2.8 billion, down 25.4% from the prior year.
• Cash from Investing Activities declined to -$3.2 billion in Q4 2025 per BNTX's latest filing, from -$1.1 billion in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $1.3 billion in Q1 2025 and troughed at -$3.2 billion in Q4 2025.
• A 5-year average of -$588.0 million and a median of -$83.8 million in 2022 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2021 and 2023: Cash from Investing Activities surged 96043426.27% in 2021, then slumped 2883.12% in 2023.
• Over 5 years, Cash from Investing Activities stood at $114.3 million in 2021, then jumped by 43.73% to $164.3 million in 2022, then plunged by 1865.35% to -$2.9 billion in 2023, then soared by 122.36% to $648.3 million in 2024, then tumbled by 589.38% to -$3.2 billion in 2025.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$3.2 billion, -$1.1 billion, and -$72.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.